Onvansertib,bevacizumab
cardiff oncology,roche
['rectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'colorectal']
cardiff oncology announces new preclinical and clinical data from program in kras-mutated metastatic colorectal cancer (mcrc) at the esmo congress 2022 
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.